Table of Contents

company-logo

Shandong Sinobioway Biomedicine Co., Ltd. manufactures and supplies trimethyl orthoformate, triethyl orthoformate, trimethyl orthoacetate, phosphorous acid, ethyl formate, nerve growth factor, and alfaron in China. The company also provides NOBEX, a murine nerve growth factor for injection; Anferon, a human recombinant interferon alpha 2b injection; and Jaferon, a human recombinant interferon alpha 2b spray. In addition, it offers Healive, an inactivated hepatitis A vaccine; Bilive, a combined hepatitis A and B Vaccine; Panflu, a pandemic influenza vaccine; Anflu, a preservative-free influenza virus vaccine; Panflu.1, a Type A H1N1 influenza vaccine; etc. Further, the company exports its products to approximately 20 counties and regions in Europe and the United States. Shandong Sinobioway Biomedicine Co., Ltd. was founded in 2000 and is headquartered in Zibo, China.

Shandong Sinobioway Biomedicine Dividend Announcement

• Shandong Sinobioway Biomedicine announced a annually dividend of ¥0.05 per ordinary share which will be made payable on . Ex dividend date: 2016-06-21
• Shandong Sinobioway Biomedicine's trailing twelve-month (TTM) dividend yield is -%
• Shandong Sinobioway Biomedicine's payout ratio for the trailing twelve months (TTM) is -1.32%

Shandong Sinobioway Biomedicine Dividend History

Ex-Div dateDividend amountDividend typePay date
2016-06-21¥0.05annually
2014-06-06¥0.50annually
2013-05-22¥0.50annually
2012-04-18¥0.50annually
2011-07-08¥0.40annually

Shandong Sinobioway Biomedicine Dividend per year

Shandong Sinobioway Biomedicine Dividend growth

Shandong Sinobioway Biomedicine Dividend Yield

Shandong Sinobioway Biomedicine current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Shandong Sinobioway Biomedicine stock? Use our calculator to estimate your expected dividend yield:

Shandong Sinobioway Biomedicine Financial Ratios

P/E ratio-9.36
PEG ratio0.96
P/B ratio1.56
ROE-16.85%
Payout ratio-1.32%
Current ratio11.18
Quick ratio9.93
Cash Ratio6.02

Shandong Sinobioway Biomedicine Dividend FAQ

Does Shandong Sinobioway Biomedicine stock pay dividends?
Shandong Sinobioway Biomedicine does not currently pay dividends to its shareholders.
Has Shandong Sinobioway Biomedicine ever paid a dividend?
No, Shandong Sinobioway Biomedicine has no a history of paying dividends to its shareholders. Shandong Sinobioway Biomedicine is not known for its dividend payments.
Why doesn't Shandong Sinobioway Biomedicine pay dividends?
There are several potential reasons why Shandong Sinobioway Biomedicine would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Shandong Sinobioway Biomedicine ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Shandong Sinobioway Biomedicine has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Shandong Sinobioway Biomedicine a dividend aristocrat?
Shandong Sinobioway Biomedicine is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Shandong Sinobioway Biomedicine a dividend king?
Shandong Sinobioway Biomedicine is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Shandong Sinobioway Biomedicine a dividend stock?
No, Shandong Sinobioway Biomedicine is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Shandong Sinobioway Biomedicine stocks?
To buy Shandong Sinobioway Biomedicine you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Shandong Sinobioway Biomedicine stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.